Providence, RI, Aug. 09, 2023 (GLOBE NEWSWIRE) — Ocean Biomedical, Inc. (NASDAQ: OCEA), a next-generation biopharma company working to accelerate the development and commercialization of compelling new biopharma discoveries, is sharing collective analyst research coverage from three firms with current “Buy” recommendations and share price targets currently averaging $18.21. EF…Read More
OCEA Share Price Target Now Averaging 1821 Based on Research and Development Progress in Three Promising Programs Generating Novel Treatment Candidates for Cancer Malaria and Fibrosis
